WallStSmart
VTGN

VistaGen Therapeutics Inc

NASDAQ: VTGN · HEALTHCARE · BIOTECHNOLOGY

$0.61
+2.94% today

Updated 2026-04-30

Market cap
$23.64M
P/E ratio
P/S ratio
29.96x
EPS (TTM)
$-1.90
Dividend yield
52W range
$0 – $5
Volume
0.7M

VistaGen Therapeutics Inc (VTGN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-4814.00$-14434.00$-22756.00$-6878.00$-3.57M$-3.46M$-2.13M$-2.77M$-4.81M$-7.26M$-9.06M$-14.53M$-15.76M$-12.07M$-45.26M$-49.72M$-25.81M$-42.10M
Capital expenditures$0.00$1284.00$0.00$0.00$32400.00$135400.00$9600.00$26300.00$26300.00$239100.00$1600.00$174000.00$275400.00$275400.00$200400.00$212000.00$61000.00$191000.00
Depreciation
Stock-based comp$1.59M$1.24M$1.14M$2.46M$4.04M$851300.00$2.34M$3.44M$3.82M$2.31M$3.48M$3.34M$2.18M$4.32M
Free cash flow$-4814.00$-15718.00$-22756.00$-6878.00$-3.60M$-3.60M$-2.14M$-2.80M$-4.83M$-7.50M$-9.06M$-14.70M$-16.03M$-12.35M$-45.46M$-49.93M$-25.87M$-42.29M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$1.26B$1.03B$1.14B$1.26B$1.39B$945.10M$866.96M
Share repurchases
Debt repayment
Net change in cash$70000.00$358500.00$2.49M$7.46M$2.72M$-11.75M$101.75M$-34.97M